• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Pharmacy based smoking cessation programs not found to be effective in increasing quit rates in community settings

byMichael WongandAlex Chan
July 9, 2022
in Chronic Disease, Public Health
Reading Time: 2 mins read
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Share on FacebookShare on Twitter

1. Participants randomized into smoking cessation training cessation sessions in community pharmacies in English and Wales were not found to have greater quit rates than control after a 11 month period.

2. There was no significant difference in the program retention rate and quit rate at 4 weeks between the pharmacies that received the training session and those that did not.

Evidence Rating Level: 1 (Excellent)

Smoking cigarettes is one of leading causes of preventable death worldwide, causing over 7 million deaths worldwide each year, with 1.2 million of the deaths being from environmental exposure to tobacco smoke. Smoking cessation has been found to be extremely effective to reduce premature mortality due to smoking at all ages. In England and Wales, the National Health Service (NHS) released a Stop Smoking Services (SSS) to provide free medication and behavioural supports for smoking cessation. These services are available in many different settings, including with general practitioners, at community pharmacies, and at specialist clinics. The NHS SSS reported a 52.4% rate of self-reported smoking cessation in 2018/2019 across all settings. However, in community pharmacies, quit rates were found to be much lower at 19%, due to a number of possible reasons including loss to follow up and poor subject selection. The STOP study was a cluster randomized controlled trial that recruited 60 pharmacies in England and Wales between April 2017 and February 2018 and randomized them in a 1:1 ratio to the intervention group and control group. The intervention was a training session involving role-plays and videos that targeted the engagement of smokers, including sessions on motivational interviewing. The primary outcome was the number ‘treated smokers’ – smokers who joined, set a firm quit date, and attended at least one consult on or before their set quit date. Between the two groups, there was no significant difference with respect to total number of treated smokers (IRR 0.75; 95% CI, 0.46-1.23, p=0.259). With respect to secondary outcomes, between the two groups, there was also no significant difference in treated smoker retention rate and quit rate at 4 weeks. Study findings suggest that comprehensive behavioural and communication skill based interventions provided by pharmacies may be an ineffective intervention tool to promote quitting cigarettes, though this will require further exploration in future studies.

Click to read the study in BMC Medicine

Image: PD

RELATED REPORTS

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

A landmark court ruling was associated with increased travel across state borders for abortion care

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: public healthsmoking
Previous Post

Characteristics of COVID-19 pneumonia patients [Classics Series]

Next Post

EMERGE trial: Delayed coronary angiogram noninferior for patients with out of hospital cardiac arrest

RelatedReports

Reduced gestational weight gain with lifestyle intervention
Chronic Disease

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

September 2, 2026
“Housing First” linked to housing stability for homeless youth with mental illness
Public Health

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

August 31, 2026
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Obstetrics

A landmark court ruling was associated with increased travel across state borders for abortion care

August 28, 2026
Natural language processing may automate data extraction from radiologic reports
Chronic Disease

Many patients using patient portals may not fully understand results of laboratory testing

August 26, 2026
Next Post
Colchicine may lower the risk of cardiovascular events in patients with coronary disease

EMERGE trial: Delayed coronary angiogram noninferior for patients with out of hospital cardiac arrest

ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]

Novel coronavirus identified from patients with pneumonia in Wuhan, China [Classics Series]

ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]

COVID-19 patient characteristics across Mainland China [Classics Series]

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)
  • Artificial intelligence based clinical exam training significantly improved medical students’ standardized clinical exam performance
  • Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.